Synlogic merges with Caldera Therapeutics in a reverse IPO deal.
Synlogic signed a merger agreement acquiring Caldera Therapeutics, with Caldera's board approving the deal to provide cash to Synlogic. The transaction is valued at $100 million.
View filing at SEC.gov →